These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Management of bisphosphonate-induced osteonecrosis of the jaw.
    Author: Schilling J.
    Journal: Northwest Dent; 2008; 87(3):34-5, 37-8, 40. PubMed ID: 18663869.
    Abstract:
    In conclusion, careful treatment planning minimizes BIONJ risk in patients with bisphosphonate exposure. The drug type, dose, potency, and duration are important factors in determining the cumulative effect on bone remodeling and resultant risk of BIONJ. Dentists and physicians should work closely to balance the risks of the oral and systemic conditions surrounding bisphosphonate use. A critical assessment of current literature is necessary to best serve our patients.
    [Abstract] [Full Text] [Related] [New Search]